CLASS II ONGOING Drug recall · Reported 15 Jan 2025 · FDA Enforcement Report

Progesterone Injection USP, 500mg per (50mg/mL) Multiple Dose Vial recalled

Eugia US is recalling Progesterone Injection USP, 500mg per (50mg/mL) Multiple Dose Vial, distributed nationwide in the US. The recall was initiated on 27 Dec 2024 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesBatch # 1PR24010, Expiry: 02/28/2027
NDC55150-306
Quantity recalled17,300 10-mL vials

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

Recall details

Recall number
D-0186-2025
FDA event ID
96073
Recalling firm
Eugia US, East Windsor, NJ
Manufacturer
Eugia US LLC
Classification
Class II
Status
Ongoing
Recall initiated
27 Dec 2024
FDA classified
7 Jan 2025
Reported
15 Jan 2025
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Particulate Matter

Timeline

27 Dec 2024Recall initiated by company
7 Jan 2025Classified by FDA+11 days
15 Jan 2025Published in enforcement report+8 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Presence of Particulate Matter: A market complaint was received of a glass piece in the vial.

Product as listed by the FDA

Progesterone Injection USP, 500mg per 10 mL (50mg/mL), 10 mL Multiple Dose Vial, Rx Only, Mfd. in India for: Eugia US LLC. E. Windsor NJ 08520 NDC # 55150-306-10

Where it was distributed

Distributed Nationwide in the USA.

Nationwide

Questions about this recall

Is Progesterone Injection USP, 500mg per (50mg/mL) Multiple Dose Vial recalled?

Yes. Eugia US recalled Progesterone Injection USP, 500mg per (50mg/mL) Multiple Dose Vial on 27 Dec 2024. The recall is Class II and its status is Ongoing. Recall number D-0186-2025.

Why was it recalled?

Presence of Particulate Matter: A market complaint was received of a glass piece in the vial.

Which lots are affected?

Batch # 1PR24010, Expiry: 02/28/2027

Where was it sold?

Distributed Nationwide in the USA.

What should I do if I have it?

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 21 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Eugia US

All 17

Other Progesterone recalls

All 7